Literature DB >> 33601916

High-Plex RNA Expression Profiling of Formalin-Fixed Paraffin-Embedded Synovial Membrane Indicates Potential Mechanism of Mesenchymal Stromal Cells in the Mitigation of Posttraumatic Osteoarthritis.

Laura E Keller1, Lisa A Fortier2, Michelle L Delco2, Mana Okudaira1, Liliya Becktell1, Marta Cercone2.   

Abstract

Entities:  

Keywords:  NanoString; mesenchymal stem cells; synovial membrane

Mesh：

Substances：

Year:  2021        PMID： 33601916      PMCID： PMC8804794          DOI： 10.1177/1947603521993521

Source DB:  PubMed          Journal:  Cartilage        ISSN： 1947-6035            Impact factor:   3.117


× No keyword cloud information.
  14 in total

Review 1.  Evaluating Robustness and Sensitivity of the NanoString Technologies nCounter Platform to Enable Multiplexed Gene Expression Analysis of Clinical Samples.

Authors:  Margaret H Veldman-Jones; Roz Brant; Claire Rooney; Catherine Geh; Hollie Emery; Chris G Harbron; Mark Wappett; Alan Sharpe; Michael Dymond; J Carl Barrett; Elizabeth A Harrington; Gayle Marshall
Journal:  Cancer Res       Date:  2015-06-11       Impact factor: 12.701

2.  CCL5 Promotes Resolution-Phase Macrophage Reprogramming in Concert with the Atypical Chemokine Receptor D6 and Apoptotic Polymorphonuclear Cells.

Authors:  Miran Aswad; Simaan Assi; Sagie Schif-Zuck; Amiram Ariel
Journal:  J Immunol       Date:  2017-07-03       Impact factor: 5.422

3.  CCL2, CCL5, and IGF-1 participate in the immunomodulation of osteogenesis during M1/M2 transition in vitro.

Authors:  Luis A Córdova; Florence Loi; Tzu-Hua Lin; Emmanuel Gibon; Jukka Pajarinen; Akira Nabeshima; Laura Lu; Zhenyu Yao; Stuart B Goodman
Journal:  J Biomed Mater Res A       Date:  2017-08-21       Impact factor: 4.396

4.  Modulation of monocytes matrix metalloproteinase-2, MT1-MMP and TIMP-2 by interferon-gamma and -beta: implications to multiple sclerosis.

Authors:  Yanina Galboiz; Sarah Shapiro; Nitza Lahat; Ariel Miller
Journal:  J Neuroimmunol       Date:  2002-10       Impact factor: 3.478

Review 5.  Immunopathogenesis of osteoarthritis.

Authors:  Abdul Haseeb; Tariq M Haqqi
Journal:  Clin Immunol       Date:  2013-01-06       Impact factor: 3.969

6.  Exogenous mesenchymal stem cells localize to the kidney by means of CD44 following acute tubular injury.

Authors:  M B Herrera; B Bussolati; S Bruno; L Morando; G Mauriello-Romanazzi; F Sanavio; I Stamenkovic; L Biancone; G Camussi
Journal:  Kidney Int       Date:  2007-05-16       Impact factor: 10.612

7.  Immunomodulation By Therapeutic Mesenchymal Stromal Cells (MSC) Is Triggered Through Phagocytosis of MSC By Monocytic Cells.

Authors:  Samantha F H de Witte; Franka Luk; Jesus M Sierra Parraga; Madhu Gargesha; Ana Merino; Sander S Korevaar; Anusha S Shankar; Lisa O'Flynn; Steve J Elliman; Debashish Roy; Michiel G H Betjes; Philip N Newsome; Carla C Baan; Martin J Hoogduijn
Journal:  Stem Cells       Date:  2018-02-01       Impact factor: 6.277

8.  The life and fate of mesenchymal stem cells.

Authors:  Elke Eggenhofer; Franka Luk; Marc H Dahlke; Martin J Hoogduijn
Journal:  Front Immunol       Date:  2014-05-19       Impact factor: 7.561

Review 9.  Molecular mechanisms that influence the macrophage m1-m2 polarization balance.

Authors:  Nan Wang; Hongwei Liang; Ke Zen
Journal:  Front Immunol       Date:  2014-11-28       Impact factor: 7.561

Review 10.  Synovitis in osteoarthritis: current understanding with therapeutic implications.

Authors:  Alexander Mathiessen; Philip G Conaghan
Journal:  Arthritis Res Ther       Date:  2017-02-02       Impact factor: 5.156
View more
  1 in total

Review 1.  Cell-based therapies have disease-modifying effects on osteoarthritis in animal models. A systematic review by the ESSKA Orthobiologic Initiative. Part 1: adipose tissue-derived cell-based injectable therapies.

Authors:  Carlotta Perucca Orfei; Angelo Boffa; Yosef Sourugeon; Lior Laver; Jérémy Magalon; Mikel Sánchez; Thomas Tischer; Giuseppe Filardo; Laura de Girolamo
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2022-09-14       Impact factor: 4.114
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.